Cargando…
DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature
DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect. Here, the authors have presented a brief appraisal of DPP-4 inhibitors, their modes of action, and the clinical efficiency of currently available drugs based...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242023/ https://www.ncbi.nlm.nih.gov/pubmed/37287751 http://dx.doi.org/10.3389/fmolb.2023.1130625 |